Genomic Data Commons heralds new era of data sharing for cancer research
The Genomic Data Commons , a next-generation platform that enables unprecedented data access, analysis and sharing for cancer research, publicly launched at the University of Chicago on June 6, opening...
View ArticleWhen cancer threatened pregnancy, "I would have died from a broken heart"
Assoc. Prof. Blase Polite creates specialized cancer treatment for pregnant patient
View ArticleGrad student’s discovery could enable rapid screening of anti-cancer compounds
It isn’t often that a graduate student makes a spectacular technical leap in his field, or invents a process that can have a significant impact on a real-world problem. Di Liu did both. A chemistry...
View ArticleCancer Immunotherapy At A Crossroads
Asst. Prof. Jason Luke discusses genetic interventions in cancer immunotherapy treatments
View ArticleNanoparticle drug cocktail could help treat lethal cancers
Cancer treatments that mobilize the body’s immune system to fight the disease have generated a lot of excitement in the past few years. One promising form of immunotherapy called checkpoint blockade...
View ArticleProf. Thomas Gajewski honored for pioneering cancer research
The National Cancer Institute , a branch of the National Institutes of Health, has awarded an Outstanding Investigator Award to Prof. Thomas Gajewski. The award supports scientists who demonstrate...
View ArticleSpecific microbes in digestive tract can boost success for cancer immunotherapy
In the Jan. 5 issue of Science , researchers from the University of Chicago Medicine show that specific strains of commensal bacteria—the swarms of microorganisms naturally dwelling in the...
View ArticleScientists build army of metal-organic nanoflowers to treat cancer
Doctors have been using radiation to treat cancer for more than a hundred years, but it’s always been a delicate art to direct treatment while avoiding healthy tissue. To help them, scientists with the...
View Article‘Zombie’ gene protects elephants against cancer
An estimated 17 percent of humans worldwide die from cancer, but less than five percent of captive elephants—who live for about 70 years, and have about 100 times as many potentially cancerous cells as...
View ArticleElephants rarely get cancer. Here's why this matters to humans
Asst. Prof. Vincent J. Lynch explains why elephants are cancer-resistant
View ArticleThe ‘Zombie Gene’ That May Protect Elephants From Cancer
Asst. Prof. Vincent J. Lynch explains why elephants are cancer-resistant
View Article8 Silent Signs of Cervical Cancer You Should Never Ignore
Prof. John Moroney discusses signs of cervical cancer
View ArticleDr. Smith Discusses the Diagnosis of Double-Hit Lymphoma
Video: Prof. Sonali Smith discusses lymphoma diagnosis
View ArticleDr. Desai on Phase I Study of Entrectinib in Solid Tumors
Video: Asst. Prof. Ami Desai discusses the use of entrectinib in patients with solid tumors
View ArticleTeaching the immune system to fight cancer
Editor's note: This piece was adapted from a story that originally appeared in the University of Chicago Magazine . When telling the story of immunotherapy and cancer and how the two battle it out,...
View ArticleRepurposing older drugs could raise new hope for breast cancer treatment
An estimated 15 to 20 percent of all breast cancer patients are “triple negative,” meaning women lack three crucial treatment targets—the estrogen receptor, the progesterone receptor and human...
View ArticleInnovative drug delivery improves effectiveness of cancer immunotherapy
Even after decades of research, cancer remains difficult to treat, in part because of its ability to evade the body’s natural defenses found in the immune system. Immunotherapy, which stimulates the...
View ArticleUChicago, partners collaborate with industry to develop next-generation...
A new collaboration between Celgene Corp. and the Recombinant Antibody Network , a consortium comprising research groups from the University of California-San Francisco, the University of Chicago and...
View ArticleGut bacteria can dramatically amplify cancer immunotherapy
By introducing a particular strain of bacteria into the digestive tracts of mice with melanoma, researchers at the University of Chicago were able to boost the ability of the animal’s immune systems to...
View Article
